Achillion Pharmaceuticals, Inc. (ACHN)
$1.87
-0.05 (-2.61%)
| CAPS Rating |
|
|---|---|
| Open | $1.87 |
| Previous Close | $1.92 |
| Daily Range | $1.85 - $1.88 |
| 52-Week Range | $0.65 - $2.42 |
| Market Cap | $49.84M |
| P/E Ratio | 0.21 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 5,844 |
| Average Daily Volume | 38,000 |
ACHN
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ACHN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ACHN News and Commentary
- Achillion Pharma: Funding in Place to Advance HCV Pipeline – Blog at The Motley Fool
Related News and Articles
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Finally Convinced? Benlysta Works! – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool
- Earnings? Yawn. Trial Data? Moving! – The Motley Fool
- Small and Volatile, but Not for Long – The Motley Fool
- Saved by Emerging Markets. Sort Of. – The Motley Fool
RSS Headlines
Fool UK
